Growing community of inventors

Dublin, Ireland

Orla Cunningham

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 21

Orla CunninghamJun Zhang (3 patents)Orla CunninghamHaichun Huang (3 patents)Orla CunninghamBrigitte Devaux (3 patents)Orla CunninghamPeter Brams (3 patents)Orla CunninghamKarla Ann Henning (3 patents)Orla CunninghamTetsuya Ishino (3 patents)Orla CunninghamRobert Arch (3 patents)Orla CunninghamJoel Bard (3 patents)Orla CunninghamWilliam Finlay (3 patents)Orla CunninghamCiara Reilly (3 patents)Orla CunninghamMichelle M Mader (1 patent)Orla CunninghamMichelle Madar (1 patent)Orla CunninghamMichelle Mader (1 patent)Orla CunninghamJun Zhang (1 patent)Orla CunninghamCiara Reilly (1 patent)Orla CunninghamOrla Cunningham (3 patents)Jun ZhangJun Zhang (98 patents)Haichun HuangHaichun Huang (80 patents)Brigitte DevauxBrigitte Devaux (32 patents)Peter BramsPeter Brams (28 patents)Karla Ann HenningKarla Ann Henning (22 patents)Tetsuya IshinoTetsuya Ishino (7 patents)Robert ArchRobert Arch (4 patents)Joel BardJoel Bard (4 patents)William FinlayWilliam Finlay (3 patents)Ciara ReillyCiara Reilly (3 patents)Michelle M MaderMichelle M Mader (3 patents)Michelle MadarMichelle Madar (1 patent)Michelle MaderMichelle Mader (1 patent)Jun ZhangJun Zhang (26 patents)Ciara ReillyCiara Reilly (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (3 from 4,455 patents)

2. Bristol-myers Squibb Compnay (3 from 3,684 patents)


3 patents:

1. 12372536 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

2. 11474112 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

3. 9683998 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…